Sponsor content
330 result(s) found, displaying 221 to 230
-
Australian public assessment report (AusPar)Australian Public Assessment for Benralizumab
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Australian public assessment report (AusPar)Australian Public Assessment for Olaparib
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SYNAGIS palivizumab (rmc) 100 mg / 1 mL solution for injection vial.
-
Prescription medicine registrationActive ingredients: durvalumab (rch).
-
Prescription medicine registrationActive ingredients: glycopyrronium bromide (glycopyrrolate); formoterol (eformoterol) fumarate dihydrate.
-
-